{"title":"Frequently Purchased Peptides","description":"\u003cdiv class=\"qMYqUG_convSearchResultHighlightRoot\"\u003e\n\u003cdiv class=\"\" data-turn-id-container=\"request-WEB:3ae94fa6-aee7-4573-b589-8a2e68149535-2\" data-is-intersecting=\"true\"\u003e\n\u003csection class=\"text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [\u0026amp;:has([data-writing-block])\u0026gt;*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" data-turn-id=\"request-WEB:3ae94fa6-aee7-4573-b589-8a2e68149535-2\" data-turn-id-container=\"request-WEB:3ae94fa6-aee7-4573-b589-8a2e68149535-2\" data-testid=\"conversation-turn-6\" data-turn=\"assistant\"\u003e\n\u003cdiv class=\"text-base my-auto mx-auto pb-10 [--thread-content-margin:var(--thread-content-margin-xs,calc(var(--spacing)*4))] @w-sm\/main:[--thread-content-margin:var(--thread-content-margin-sm,calc(var(--spacing)*6))] @w-lg\/main:[--thread-content-margin:var(--thread-content-margin-lg,calc(var(--spacing)*16))] px-(--thread-content-margin)\"\u003e\n\u003cdiv data-conversation-screenshot-content=\"\" class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\"\u003e\n\u003cdiv class=\"flex max-w-full flex-col gap-4 grow\"\u003e\n\u003cdiv data-message-author-role=\"assistant\" data-message-id=\"a412925d-c15b-4c9c-83b1-4ff0301d7036\" data-turn-start-message=\"true\" dir=\"auto\" data-message-model-slug=\"gpt-5-5-pro\" class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal outline-none keyboard-focused:focus-ring [.text-message+\u0026amp;]:mt-1\" tabindex=\"0\"\u003e\n\u003cdiv class=\"flex w-full flex-col gap-1 empty:hidden\"\u003e\n\u003cdiv class=\"markdown prose dark:prose-invert wrap-break-word w-full dark markdown-new-styling\"\u003e\n\u003cp data-start=\"966\" data-end=\"1111\" data-is-last-node=\"\" data-is-only-node=\"\" class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong data-start=\"966\" data-end=\"1003\"\u003eShop Featured Peptides\u003c\/strong\u003e\u003cbr data-start=\"1003\" data-end=\"1006\"\u003eChoose from Tirzepatide, Retatrutide, or GHK-Cu — each available as its own individual peptide selection.\u003cspan aria-hidden=\"true\" class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"z-0 flex min-h-[46px] justify-start\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","products":[{"product_id":"tirzepatide","title":"Tirzepatide (Dual Agonist | GLP-1 \/ GIP | Metabolic Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eTirzepatide has been studied extensively in human clinical trials as a \u003cstrong\u003edual GIP\/GLP-1 receptor agonist\u003c\/strong\u003e. In approved medical settings, it is used as a once-weekly injectable medication for type 2 diabetes under the brand \u003cstrong\u003eMounjaro\u003c\/strong\u003e, and for chronic weight management under \u003cstrong\u003eZepbound\u003c\/strong\u003e in some countries. Its main research interest comes from its ability to activate two incretin pathways involved in glucose control, appetite signaling, insulin response, gastric emptying, and body-weight regulation.\u003c\/p\u003e\n\u003ch3\u003ePotential benefits observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSignificant body-weight reduction\u003c\/strong\u003e\u003cbr\u003eIn obesity studies, tirzepatide produced substantial average weight loss compared with placebo. SURMOUNT-1 reported body-weight reductions in the range of about \u003cstrong\u003e16% to 22.5%\u003c\/strong\u003e, depending on dose group.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eImproved glycemic control\u003c\/strong\u003e\u003cbr\u003eIn type 2 diabetes studies, tirzepatide has shown strong reductions in \u003cstrong\u003eHbA1c\u003c\/strong\u003e, fasting glucose, and overall markers of blood-sugar control. SURPASS trial analyses describe consistent reductions in both HbA1c and body weight across studied doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eDual-pathway metabolic activity\u003c\/strong\u003e\u003cbr\u003eBecause tirzepatide activates both \u003cstrong\u003eGIP\u003c\/strong\u003e and \u003cstrong\u003eGLP-1\u003c\/strong\u003e receptors, it gives researchers a way to study combined incretin signaling rather than GLP-1 activity alone.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAppetite and satiety pathway effects\u003c\/strong\u003e\u003cbr\u003eHuman studies suggest tirzepatide can influence appetite regulation, food intake behavior, and satiety signaling, which may contribute to weight-related outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential cardiometabolic improvements\u003c\/strong\u003e\u003cbr\u003eWeight loss and glycemic improvement may also be associated with improvements in metabolic markers such as waist circumference, blood pressure, insulin sensitivity, and lipid-related parameters, depending on the study population.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOnce-weekly dosing in approved formulations\u003c\/strong\u003e\u003cbr\u003eIts long-acting structure supports once-weekly administration in approved pharmaceutical products, which is one reason it is widely studied in metabolic medicine.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal side effects are common\u003c\/strong\u003e\u003cbr\u003eNausea, diarrhea, vomiting, constipation, abdominal discomfort, and decreased appetite are among the most commonly reported effects. These often occur during dose escalation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot suitable for everyone\u003c\/strong\u003e\u003cbr\u003eFDA labeling lists contraindications for people with a personal or family history of \u003cstrong\u003emedullary thyroid carcinoma\u003c\/strong\u003e or \u003cstrong\u003eMEN 2\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRequires medical supervision when used clinically\u003c\/strong\u003e\u003cbr\u003eIn human use, tirzepatide should only be used as an approved medication prescribed and monitored by a licensed healthcare professional. It is not appropriate to use research-grade or unapproved peptide products in humans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential for dehydration or kidney-related issues\u003c\/strong\u003e\u003cbr\u003eSevere vomiting or diarrhea can increase dehydration risk, which may worsen kidney function in vulnerable patients.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible gallbladder and pancreatitis concerns\u003c\/strong\u003e\u003cbr\u003eGLP-1–based therapies are commonly monitored for symptoms related to gallbladder disease and pancreatitis risk.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWeight regain can occur after discontinuation\u003c\/strong\u003e\u003cbr\u003eLike many chronic metabolic treatments, benefits may decrease when therapy stops, especially without sustained lifestyle and medical management.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical data on tirzepatide is promising, especially for metabolic and weight-related outcomes, but human use should only involve approved, regulated medication under licensed medical supervision. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51939087221024,"sku":null,"price":1700.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 15mg","offer_id":51939087253792,"sku":null,"price":2100.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 30mg","offer_id":51939087286560,"sku":null,"price":2500.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 15mg","offer_id":51939282583840,"sku":null,"price":3800.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 30mg","offer_id":51939282616608,"sku":null,"price":4300.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/7c3c37f9-8903-42ed-90c0-e38d808e2b4a.png?v=1783142957"},{"product_id":"retatrutide","title":"Retatrutide (Triple Agonist | GLP-1 \/ GIP \/ Glucagon | Metabolic Pathway Research)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003eRetatrutide is an investigational synthetic peptide being studied as a \u003cstrong\u003etriple hormone receptor agonist\u003c\/strong\u003e, targeting \u003cstrong\u003eGIP, GLP-1, and glucagon receptors\u003c\/strong\u003e. This triple-action design makes it one of the most scientifically interesting compounds in current metabolic research because it engages three major pathways involved in appetite regulation, glucose control, insulin response, lipid metabolism, and energy expenditure.\u003c\/p\u003e\n\u003cp\u003eUnlike tirzepatide, which targets GIP and GLP-1, retatrutide adds glucagon receptor activity. In research, glucagon receptor activation is especially interesting because it may influence energy expenditure, fat metabolism, and liver-related metabolic pathways. This is why retatrutide is being studied not only for obesity and type 2 diabetes, but also for broader metabolic dysfunction research, including liver-fat-related outcomes. Phase 2 studies have reported meaningful weight-loss and glycemic improvements, but retatrutide remains investigational and is not an approved medication.\u003c\/p\u003e\n\u003ch3\u003ePotential benefits observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eVery strong body-weight reduction\u003c\/strong\u003e\u003cbr\u003eIn a phase 2 obesity trial, retatrutide produced large, dose-dependent body-weight reductions over 48 weeks, making it one of the most closely watched investigational metabolic peptides in clinical research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTriple-pathway metabolic activity\u003c\/strong\u003e\u003cbr\u003eRetatrutide activates GIP, GLP-1, and glucagon receptors, giving researchers a way to study combined incretin and glucagon signaling in one molecule. This may help explain its strong effects on body-weight and metabolic markers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAppetite and satiety effects\u003c\/strong\u003e\u003cbr\u003eGLP-1 and GIP receptor activity are associated with appetite signaling, food intake regulation, and satiety pathways. This makes retatrutide important for research into hunger control and long-term energy balance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible increase in energy expenditure\u003c\/strong\u003e\u003cbr\u003eThe added glucagon receptor activity is scientifically important because glucagon signaling may influence energy use, lipid metabolism, and fat-burning pathways. This separates retatrutide from GLP-1-only and dual GIP\/GLP-1 compounds.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGlycemic control improvements\u003c\/strong\u003e\u003cbr\u003eIn people with type 2 diabetes, phase 2 research reported clinically meaningful improvements in glycemic control along with robust body-weight reductions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eInterest in liver-fat and metabolic dysfunction research\u003c\/strong\u003e\u003cbr\u003eRetatrutide has been highlighted in research involving obesity, type 2 diabetes, and NAFLD-related metabolic pathways, making it useful for studying how weight loss, glucose control, and liver-fat metabolism may connect.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eOnce-weekly study design\u003c\/strong\u003e\u003cbr\u003eClinical studies have evaluated retatrutide as a once-weekly injectable investigational compound, which is relevant for pharmacokinetic and long-acting peptide research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential next-generation metabolic research model\u003c\/strong\u003e\u003cbr\u003eBecause it targets three receptors instead of one or two, retatrutide is often viewed as a next-generation research compound for studying multi-receptor metabolic signaling.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed in human studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eStill investigational\u003c\/strong\u003e\u003cbr\u003eRetatrutide is not currently an approved medication. It is still being evaluated in clinical development, so its full long-term safety profile is not yet established.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eGastrointestinal side effects may occur\u003c\/strong\u003e\u003cbr\u003eAs with GLP-1 and incretin-based compounds, nausea, vomiting, diarrhea, constipation, reduced appetite, and abdominal discomfort are commonly discussed side effects in this class of research.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePotential for excessive weight loss\u003c\/strong\u003e\u003cbr\u003eBecause retatrutide has shown strong body-weight effects in studies, researchers and clinicians monitor concerns such as excessive weight reduction, loss of lean mass, nutritional issues, or tolerability problems.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eMore complex mechanism\u003c\/strong\u003e\u003cbr\u003eTriple receptor activity may make results harder to interpret compared with single GLP-1 or dual GIP\/GLP-1 agonists. Effects may vary depending on dose, receptor expression, study population, and metabolic condition.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman use requires strict medical supervision\u003c\/strong\u003e\u003cbr\u003eSince retatrutide is investigational and not approved, it should not be used outside proper clinical research settings. Research-grade or unapproved products should not be used in humans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical data on retatrutide is scientifically promising, especially for body-weight, glucose-control, and metabolic-pathway research. However, retatrutide remains investigational and should only be studied under appropriate research conditions. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 10mg","offer_id":51941113266464,"sku":null,"price":1800.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 15mg","offer_id":51941113299232,"sku":null,"price":2100.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 30mg","offer_id":51941113332000,"sku":null,"price":2700.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 15mg","offer_id":51941113364768,"sku":null,"price":3900.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 30mg","offer_id":51941113397536,"sku":null,"price":4400.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/63dc7560-b312-460e-a8f7-e3222dbd565e.png?v=1783190539"},{"product_id":"ghk-cu","title":"GHK-Cu (Copper-Binding Tripeptide | Skin \u0026 Tissue Remodeling Studies)","description":"\u003ch3 class=\"additional-info-sections__item-title\"\u003eProduct Info\u003c\/h3\u003e\n\u003cp class=\"additional-info-sections__item-description\" id=\"additional-info-painfo_01KQSQ497G7DW5GNY4BXXM9HP0\" data-v-9492fc08=\"\"\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e, also known as copper tripeptide-1 or glycyl-L-histidyl-L-lysine copper complex, is an investigational copper-binding peptide commonly discussed in skin, hair, wound-healing, tissue-repair, and regenerative research. It is a naturally occurring tripeptide complex associated with copper signaling and is often studied for its possible relationship to extracellular matrix remodeling, collagen-related pathways, antioxidant response, and tissue-repair mechanisms. PubChem lists GHK-Cu as a copper peptide complex with the formula \u003cstrong\u003eC₂₈H₄₈CuN₁₂O₈\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eUnlike metabolic peptides such as tirzepatide, GHK-Cu is not designed around GLP-1, GIP, glucagon, appetite, or glucose-control receptor activity. Instead, scientific interest centers on copper-peptide signaling, skin-quality research, hair and follicle models, wound-healing investigation, connective-tissue support, inflammation-response pathways, and broader regenerative study. Reviews describe GHK-Cu as a peptide of interest in human skin research and tissue-regenerative mechanisms, while still emphasizing the need to avoid overextending claims beyond the available evidence.\u003c\/p\u003e\n\u003ch3\u003ePotential research interests observed in studies\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSkin and collagen research\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is widely discussed in skin-related research involving collagen support, dermal remodeling, skin appearance, elasticity, and extracellular matrix activity. This is one of the most common areas where copper peptides are studied.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eWound-healing and tissue-repair models\u003c\/strong\u003e\u003cbr\u003eResearch interest often focuses on wound-healing pathways, tissue-repair signaling, and recovery-related mechanisms. Reviews describe GHK-Cu as a copper peptide associated with regenerative and protective actions in skin and tissue models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHair and follicle research\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is frequently discussed in relation to scalp, follicle, and hair-support research. These discussions are mainly investigational and should not be presented as proven treatment outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eConnective-tissue support research\u003c\/strong\u003e\u003cbr\u003eBecause GHK-Cu is associated with matrix remodeling and collagen-related pathways, it is often studied in broader connective-tissue and tissue-quality research contexts.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCopper-peptide signaling\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is studied as a copper-binding peptide complex, which makes it relevant to research involving copper transport, peptide-metal coordination, cellular signaling, and redox-related mechanisms.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eAntioxidant and inflammation-response research\u003c\/strong\u003e\u003cbr\u003eScientific discussion around GHK-Cu often includes antioxidant response, inflammatory signaling, and tissue-stress pathways. These findings should be understood as research interests, not confirmed clinical benefits.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCosmetic and dermatology research interest\u003c\/strong\u003e\u003cbr\u003eGHK-Cu has a long history of discussion in cosmetic science, especially around skin-aging, texture, and appearance-related research. Public interest has grown, but many consumer-facing claims still exceed what controlled clinical evidence can firmly establish.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eStable topical-research interest\u003c\/strong\u003e\u003cbr\u003eGHK-Cu is commonly discussed in topical and cosmetic research contexts because of its copper-peptide identity and skin-focused study history. Injectable or unapproved human use should not be implied or promoted.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eLimitations and risks observed or discussed\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eHuman clinical evidence is still limited\u003c\/strong\u003e\u003cbr\u003eAlthough GHK-Cu has more cosmetic and skin-related research history than many newer peptides, broad human claims around skin regeneration, hair growth, anti-aging, wound healing, or systemic benefits still require stronger controlled clinical evidence.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eNot an approved medication for disease treatment\u003c\/strong\u003e\u003cbr\u003eGHK-Cu should not be marketed as a treatment for wounds, hair loss, skin disease, scarring, inflammation, injury recovery, or any medical condition.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRoute of use matters\u003c\/strong\u003e\u003cbr\u003eTopical cosmetic discussion is different from injection or systemic exposure. Research-grade or unapproved peptide products should not be used in humans, especially by injection.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible irritation or sensitivity\u003c\/strong\u003e\u003cbr\u003eCopper peptide products may cause irritation, sensitivity, redness, or other local reactions in some topical-use contexts. These risks may vary depending on concentration, formulation, and individual skin response.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eCopper-related formulation concerns\u003c\/strong\u003e\u003cbr\u003eBecause GHK-Cu involves copper complexation, improper formulation, instability, concentration errors, or contamination may affect product quality and safety.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePossible risks from unregulated products\u003c\/strong\u003e\u003cbr\u003eProducts sold online as research chemicals may carry risks related to contamination, inaccurate concentration, mislabeling, sterility issues, or lack of regulated manufacturing oversight.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eClaims may exceed the evidence\u003c\/strong\u003e\u003cbr\u003eMany online claims around \"anti-aging,\" \"hair growth,\" \"scar repair,\" \"skin regeneration,\" or \"wound healing\" go beyond what has been proven in controlled human trials.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch3\u003eWebsite-safe closing line\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eGHK-Cu is scientifically interesting for copper-peptide signaling, skin, hair, wound-healing, connective-tissue, and regenerative research, but broad human safety and effectiveness claims remain insufficiently established. GHK-Cu should not be marketed as a treatment for any medical condition, and unapproved human use should be avoided. Sterile Labs products are strictly for research use only.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"My Store","offers":[{"title":"Vial \/ 50mg","offer_id":51941115167008,"sku":null,"price":1300.0,"currency_code":"PHP","in_stock":true},{"title":"Vial \/ 100mg","offer_id":51941115199776,"sku":null,"price":1400.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 50mg","offer_id":51941115265312,"sku":null,"price":3000.0,"currency_code":"PHP","in_stock":true},{"title":"Pen \/ 100mg","offer_id":51941115298080,"sku":null,"price":3100.0,"currency_code":"PHP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1010\/5205\/5840\/files\/f169acc0-1f0d-433d-b982-8b10cc1a3366_1944fc4e-5c64-4d02-b543-9c3be3d9378d.png?v=1783191000"}],"url":"https:\/\/sterilelabs.shop\/collections\/frequently-purchased-peptides.oembed","provider":"Sterile Labs","version":"1.0","type":"link"}